My watch list
my.bionity.com  
Login  

7 Current news of Med BioGene

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Med BioGene Announces Collaboration to Develop Genetic Biomarkers for Lymphoma and Leukemia

21-Mar-2007

Med BioGene Inc. announced that it has entered into a research collaboration and option agreement with Duke University to further develop and validate MBI's genetic biomarkers for lymphoma and leukemia using its Gene Expression Profiling SystemTM. The collaboration between MBI and Duke includes, ...

more

Med BioGene Receives Funding from National Research Council Canada to Develop Genetic Biomarkers for Cardiovascular Disease

12-Mar-2007

Med BioGene Inc. announced that it has received a $307,000 contribution from the National Research Council Canada Industrial Research Assistance Program (NRC-IRAP) to develop genetic biomarkers for cardiovascular disease (CVD). "We believe that Med BioGene's expertise in gene expression and the ...

more

Med BioGene Appoints Dr. Richard C. Cook to its Scientific Advisory Board

05-Mar-2007

Med BioGene Inc. announced that it has appointed Dr. Richard C. Cook, MD, M.Sc., FRCSC, to its Scientific Advisory Board. Dr. Cook is a Clinical Associate Professor of Surgery with the Department of Cardiovascular Surgery at the University of British Columbia and is an expert in complex mitral ...

more

Med BioGene announces futher promising results on the diagnostic value of its lymphoma genetic biomarkers

05-Feb-2007

Med BioGene Inc. announced the results of its latest pre-clinical studies involving its Gene Expression Profiling System(TM) for diagnosing lymphoma. 110 RNA samples derived from human lymphoma tissues, representing the seven major subtypes of lymphoma, were analyzed utilizing a 10-fold ...

more

Med BioGene reports pre-clinical results of its Diagnostic Lymphoma DNA Bioarray

08-Aug-2006

Med BioGene Inc. announced the results of its pre-clinical studies involving its Diagnostic Lymphoma Bioarray. The studies of fifty RNA samples derived from human lymphoma tissues suggest that MBI's Diagnostic Lymphoma Bioarray successfully differentiated between genes in both the diseased and ...

more

Med Biogene Inc. appoints Erinn B. Broshko as its new Chief Executive Officer and a director

23-May-2006

Med BioGene Inc. (MBI) announced the appointment of Erinn B. Broshko as Chief Executive Officer and a director of MBI. Prior to joining MBI, Mr. Broshko was a corporate and securities lawyer with the Vancouver law firm of Farris, Vaughan, Wills & Murphy LLP. Mr. Broshko's legal practice was ...

more

Med BioGene Inc. completes acquisition of Dragon-Tex (Group) Limited and $2 million financing

09-May-2006

Med BioGene Inc. announced that it completed its acquisition of Dragon-Tex (Group) Limited ("DTX"). As part of the acquisition, the shareholders of DTX exchanged their common shares for common shares of MBI on the basis of two common shares of DTX for one common share of MBI. Furthermore, ...

more

Page 1 From 1
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE